Xylem raised its 2026 adjusted EPS range on July 28, 2026, then cut it on October 27 to a midpoint below where it stood before the raise. XYL shareholders who lost money have legal rights, and an investigation into potential securities law violations is reviewing those losses.

NEW YORK, Oct. 28, 2026 /PRNewswire/ — Three months after raising its full-year outlook, Xylem Inc. (NYSE: XYL) erased the entire increase on October 27, 2026, cutting 2026 adjusted EPS guidance to $5.40-$5.45 from $5.55-$5.70 as XYL shares fell. If you lost money on XYL, you have rights, and now is the time to protect them. Find out whether you can recover your XYL losses, or contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.

On July 28, 2026, Xylem lifted its 2026 adjusted EPS range from $5.35-$5.60 to $5.55-$5.70. On that day’s earnings call, CFO William Grogan said first-half performance, share repurchases, and higher margins “more than offset the revenue headwind from electric metering delays and gives us confidence to raise the EPS range.”

Thirteen weeks later, the guidance midpoint dropped from $5.625 to $5.425. That $0.20 reduction left it $0.05 below the $5.475 midpoint in place before the July raise. The October 27 report described a quarter affected by project delays and cautious customer spending. Shareholders who suffered losses may be entitled to seek recovery whether or not they still hold their shares.

XYL shareholders who lost money are encouraged to request a free review of their recovery rights or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the XYL Investigation

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Xylem Inc. made materially false or misleading statements regarding its full-year 2026 projections, including the decision to increase the range of its adjusted EPS outlook to $5.55-$5.70 on July 28, 2026. When the Company disclosed a reduced range of $5.40-$5.45 alongside a cut to revenue guidance on October 27, 2026, the stock price declined.

Q: When did Xylem allegedly mislead investors?A: The investigation concerns statements made before the corrective disclosure that allegedly caused investors to purchase securities at inflated prices.

Q: Who is eligible to participate in the XYL investigation?A: Investors who purchased XYL stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.

Q: What is a lead plaintiff and why does it matter?A: If the investigation proceeds to legal action, a lead plaintiff is the investor the court appoints to represent the group of affected investors. Lead plaintiffs are typically investors with the largest documented losses.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my XYL shares — can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought XYL and sold at a loss may still participate in the investigation.

Q: What if my XYL losses are small — is it still worth contacting a lawyer?A: Yes. There is no minimum loss amount required to participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xyl-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-xylem-inc-302922637.html

SOURCE SueWallSt.com